Domantis, a spin-out company from the MRC, is the first to win the UK Innovation in Drug Discovery & Development Award. To read the full report please click here
Pivotal partnership seeks to transform Cystic Fibrosis research
LifeArc's Chief Scientific Officer calls for UK science to continue to be a contributor to the Horizon Europe programme.
The new antibody offers hope of an effective new treatment option for millions of people.